🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 6 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
03/12/1973 0,0093 USD
31/08/1973 0,0078 USD
05/06/1973 0,0078 USD
05/03/1973 0,0078 USD
05/12/1972 0,0078 USD
09/06/1972 0,0073 USD
02/03/1972 0,0073 USD
06/12/1971 0,0073 USD
03/09/1971 0,0073 USD
07/06/1971 0,0073 USD
02/03/1971 0,0073 USD
01/12/1970 0,0073 USD
02/09/1970 0,0066 USD
02/06/1970 0,0066 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/04/1996 28,27 28,45 27,37 28,33 +1,06% 3,80% 13.724.818
10/04/1996 29,04 29,34 27,85 28,03 -3,89% 5,13% 11.058.915
09/04/1996 29,88 29,88 29,10 29,16 -1,21% 2,59% 5.783.493
08/04/1996 29,70 29,88 28,98 29,52 -3,13% 3,01% 9.252.163
04/04/1996 30,42 30,71 30,42 30,47 +0,59% 0,98% 4.595.270
03/04/1996 30,36 30,77 30,18 30,30 +0,00% 1,96% 5.747.022
02/04/1996 30,47 30,47 30,06 30,30 +0,20% 1,37% 4.303.507
01/04/1996 29,82 30,30 29,76 30,24 +1,81% 1,80% 6.241.050
29/03/1996 30,24 30,30 29,70 29,70 -1,19% 1,97% 4.060.371
28/03/1996 30,00 30,30 29,88 30,06 -0,20% 1,39% 4.450.856
27/03/1996 31,13 31,13 29,94 30,12 -1,56% 3,83% 6.448.763
26/03/1996 29,76 30,65 29,64 30,59 +2,60% 3,41% 7.631.536
25/03/1996 29,34 30,30 29,22 29,82 -1,57% 3,66% 9.770.714
22/03/1996 31,37 31,37 30,30 30,30 -3,05% 3,42% 7.433.883
21/03/1996 30,30 31,31 30,30 31,25 +3,97% 3,35% 8.477.062
20/03/1996 29,82 30,30 29,76 30,06 +1,41% 1,80% 8.371.843
19/03/1996 30,12 30,42 29,58 29,64 -1,00% 2,77% 9.560.904
18/03/1996 30,06 30,18 29,76 29,94 +1,01% 1,39% 7.271.024
15/03/1996 29,58 30,00 29,34 29,64 +0,20% 2,22% 11.562.794
14/03/1996 29,58 30,36 29,52 29,58 +0,61% 2,82% 11.207.731
13/03/1996 30,18 30,47 29,22 29,40 -2,38% 4,15% 9.498.024
12/03/1996 30,71 30,77 29,82 30,12 -2,70% 3,11% 8.511.227
11/03/1996 30,53 31,13 30,24 30,95 +6,35% 2,93% 8.681.422
08/03/1996 31,67 31,67 28,63 29,10 -8,95% 9,60% 12.306.245
07/03/1996 31,85 32,14 31,73 31,97 +1,13% 1,31% 4.963.957
06/03/1996 32,44 32,62 31,55 31,61 -3,81% 3,31% 4.870.266
05/03/1996 32,56 32,92 32,32 32,86 +0,73% 1,83% 3.421.930
04/03/1996 32,32 32,74 32,20 32,62 +1,48% 1,66% 4.977.581
01/03/1996 31,97 32,14 31,49 32,14 +1,70% 2,05% 6.137.088
29/02/1996 31,31 32,08 31,25 31,61 +0,57% 2,67% 6.076.514